Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute on Drug Abuse (NIDA) |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00292123 |
The primary goal of this study is to determine how contingency management can best be combined with standard or high doses of methadone to increase simultaneous abstinence from heroin and cocaine.
Condition | Intervention | Phase |
---|---|---|
Opioid Dependence Cocaine Abuse |
Drug: Methadone Behavioral: Contingency Management |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Dose Comparison, Parallel Assignment, Efficacy Study |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | National Institute on Drug Abuse ( Kenzie L. Preston, Ph.D., Principal Investigator ) |
Study ID Numbers: | NIDAIRP 326, Z01 DA 000175, Z01 DA 000234, Z01 DA 000231 |
Study First Received: | February 14, 2006 |
Last Updated: | December 18, 2007 |
ClinicalTrials.gov Identifier: | NCT00292123 |
Health Authority: | United States: Food and Drug Administration |
Cocaine-Related Disorders Methadone Mental Disorders Substance-Related Disorders Disorders of Environmental Origin |